160 related articles for article (PubMed ID: 38202741)
21. TNF or EGFR inhibition equally block AKI-to-CKD transition: opportunities for etanercept treatment.
Abdelmageed MM; Kefaloyianni E; Arthanarisami A; Komaru Y; Atkinson JJ; Herrlich A
Nephrol Dial Transplant; 2023 May; 38(5):1139-1150. PubMed ID: 36269313
[TBL] [Abstract][Full Text] [Related]
22. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage.
Franzin R; Stasi A; Fiorentino M; Stallone G; Cantaluppi V; Gesualdo L; Castellano G
Front Immunol; 2020; 11():734. PubMed ID: 32457738
[TBL] [Abstract][Full Text] [Related]
23. A single administration of FGF2 after renal ischemia-reperfusion injury alleviates post-injury interstitial fibrosis.
Tan X; Tao Q; Yin S; Fu G; Wang C; Xiang F; Hu H; Zhang S; Wang Z; Li D
Nephrol Dial Transplant; 2023 Oct; 38(11):2537-2549. PubMed ID: 37243325
[TBL] [Abstract][Full Text] [Related]
24. Using circulating O-sulfotyrosine in the differential diagnosis of acute kidney injury and chronic kidney disease.
Chen S; Liu YH; Dai DP; Zhu ZB; Dai Y; Wu ZM; Zhang LP; Duan ZF; Lu L; Ding FH; Zhu JZ; Zhang RY
BMC Nephrol; 2021 Feb; 22(1):66. PubMed ID: 33622294
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic Approaches to Improve Mitochondrial Function in AKI and CKD.
Szeto HH
J Am Soc Nephrol; 2017 Oct; 28(10):2856-2865. PubMed ID: 28778860
[TBL] [Abstract][Full Text] [Related]
26. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy.
Martini A; Cumarasamy S; Beksac AT; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter JR; Badani KK
Eur Urol; 2018 Dec; 74(6):833-839. PubMed ID: 30224195
[TBL] [Abstract][Full Text] [Related]
27. Xanthine oxidase/NADPH oxidase inhibition by hydralazine attenuates acute kidney injury and prevents the transition of acute kidney injury to chronic kidney disease.
Chiang CH; Chen C; Fang SY; Lin SC; Chen JW; Chang TT
Life Sci; 2023 Aug; 327():121863. PubMed ID: 37331504
[TBL] [Abstract][Full Text] [Related]
28. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
Tampe B; Steinle U; Tampe D; Carstens JL; Korsten P; Zeisberg EM; Müller GA; Kalluri R; Zeisberg M
Kidney Int; 2017 Jan; 91(1):157-176. PubMed ID: 27692563
[TBL] [Abstract][Full Text] [Related]
29. The Reduction of Uromodulin, Complement Factor H, and Their Interaction Is Associated with Acute Kidney Injury to Chronic Kidney Disease Transition in a Four-Time Cisplatin-Injected Rat Model.
Xing Z; Gong K; Hu N; Chen Y
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047611
[TBL] [Abstract][Full Text] [Related]
30. Association between Chronic Kidney Disease or Acute Kidney Injury and Clinical Outcomes in COVID-19 Patients.
Kang SH; Kim SW; Kim AY; Cho KH; Park JW; Do JY
J Korean Med Sci; 2020 Dec; 35(50):e434. PubMed ID: 33372426
[TBL] [Abstract][Full Text] [Related]
31. Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition.
Chou YH; Chu TS; Lin SL
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():121-125. PubMed ID: 30298669
[TBL] [Abstract][Full Text] [Related]
32. Acute kidney injury as an independent predicting factor for stage 3 or higher chronic kidney disease after nephrectomy.
Yang X; Zhang T; Zhou H; Ni Z; Wang Q; Wu J; Chen Q; Qiu M; Wang Y; Fu T; Ye M; Zhang J; Xue W; Mou S
Urol Oncol; 2023 Mar; 41(3):149.e1-149.e9. PubMed ID: 36463084
[TBL] [Abstract][Full Text] [Related]
33. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
[TBL] [Abstract][Full Text] [Related]
34. Towards prevention of ischemia-reperfusion kidney injury: Pre-clinical evaluation of 6-chromanol derivatives and the lead compound SUL-138
Vogelaar PC; Nakladal D; Swart DH; Tkáčiková Ľ; Tkáčiková S; van der Graaf AC; Henning RH; Krenning G
Eur J Pharm Sci; 2022 Jan; 168():106033. PubMed ID: 34610451
[TBL] [Abstract][Full Text] [Related]
35. Acute kidney injury after nephrectomy: a new nomogram to predict postoperative renal function.
Xu L; Li C; Zhao L; Zhou B; Luo C; Man X; Luan H; Che L; Wang Y; Xu Y
BMC Nephrol; 2020 May; 21(1):181. PubMed ID: 32410656
[TBL] [Abstract][Full Text] [Related]
36. A novel multiplex biomarker panel for profiling human acute and chronic kidney disease.
Van Nynatten LR; Miller MR; Patel MA; Daley M; Filler G; Badrnya S; Miholits M; Webb B; McIntyre CW; Fraser DD
Sci Rep; 2023 Dec; 13(1):21210. PubMed ID: 38040779
[TBL] [Abstract][Full Text] [Related]
37. Chronic impairment of mitochondrial bioenergetics and β-oxidation promotes experimental AKI-to-CKD transition induced by folic acid.
Aparicio-Trejo OE; Avila-Rojas SH; Tapia E; Rojas-Morales P; León-Contreras JC; Martínez-Klimova E; Hernández-Pando R; Sánchez-Lozada LG; Pedraza-Chaverri J
Free Radic Biol Med; 2020 Jul; 154():18-32. PubMed ID: 32360615
[TBL] [Abstract][Full Text] [Related]
38. Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage.
Sharkovska Y; Kalk P; von Websky K; Relle K; Pfab T; Alter M; Fischer Y; Hocher B
Clin Lab; 2011; 57(7-8):507-15. PubMed ID: 21888014
[TBL] [Abstract][Full Text] [Related]
39. Divergent effects of AKI to CKD models on inflammation and fibrosis.
Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
[TBL] [Abstract][Full Text] [Related]
40. Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety.
Huang HJ; Chou CL; Sandar TT; Liu WC; Yang HC; Lin YC; Zheng CM; Chiu HW
Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
